Cargando...
Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
OBJECTIVES: To assess whether switching patients with suboptimally controlled pulmonary arterial hypertension from bosentan or ambrisentan to macitentan would improve six-minute walk test (6MWT) distance and World Health Organization functional class. METHODS: This was a retrospective cohort analysi...
Gardado en:
| Publicado en: | J Int Med Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567785/ https://ncbi.nlm.nih.gov/pubmed/30975046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519840130 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|